Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A decreased metabolic clearance rate of aldosterone in benign essential hypertension
W. Nowaczynski, … , O. Kuchel, J. Genest
W. Nowaczynski, … , O. Kuchel, J. Genest
Published October 1, 1971
Citation Information: J Clin Invest. 1971;50(10):2184-2190. https://doi.org/10.1172/JCI106713.
View: Text | PDF
Research Article

A decreased metabolic clearance rate of aldosterone in benign essential hypertension

  • Text
  • PDF
Abstract

Aldosterone secretion rate, metabolic clearance rate, and/or plasma concentration were determined in 16 patients with benign, uncomplicated essential hypertension and compared with those of control subjects. The mean metabolic clearance rate of aldosterone in 10 patients was significantly (P < 0.001) lower (mean 867 liters of plasma/day per m2 ±270 SD) than in a group of 7 healthy subjects (mean 1480 liters/day per m2 ±265 SD). Secretion rates in 13 patients (including the 10 already mentioned) tended to be low (83 ±43 vs. 109 ±54 μg/day) and plasma concentrations tended to be high (13.6 ±4.6 vs. 7.5 ±4.8 ng/100 ml), but neither of these differences was statistically significant.

Authors

W. Nowaczynski, O. Kuchel, J. Genest

×

Total citations by year

Year: 2017 2011 1991 1987 1986 1985 1983 1982 1980 1979 1978 1977 1976 1975 1974 1973 1972 Total
Citations: 1 1 1 2 1 1 1 1 2 2 1 3 5 6 4 1 2 35
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (35)

Title and authors Publication Year
Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension
LM Ruilope, J Tamargo
American Journal of Hypertension 2017
Clinical Features of Malignant Hypertension with Thrombotic Microangiopathy
T Akimoto, S Muto, C Ito, H Takahashi, S Takeda, Y Ando, E Kusano
Clinical and Experimental Hypertension 2011
Normotensive young men with family histories of hypertension gain weight and decrease their intraerythrocyte sodium content during a 5-year follow-up
BR Widgren, H Herlitz, O Jonsson, G Berglund, J Wikstrand, OK Andersson
Journal of Internal Medicine 1991
Arterial and Venous Systems in Essential Hypertension
ME Safar, GM London, AC Simon, YA Weiss
1987
Renin Angiotensin Aldosterone Axis, Including Aldosterone Binding Globulin and Blood Pressure in Three Species of Nonhuman Primates
D Mavoungou, W Nowaczynski, RW Cooper, JY Collet, K Fung
Journal of Medical Primatology 1987
Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio
Z Zadik, PA Levin, BP Hamilton, AA Kowarski
Hypertension 1986
The Diagnostic Value of the 24 Hour Integrated Concentration of Plasma Aldosterone
Z Zadik, P Levin, A Kowarski
Clinical and Experimental Hypertension 1985
Aldosterone-binding globulin-induced hypertension in the rat. A new experimental model
M Nowaczynski, W Nowaczynski, D Mavoungou, F Lioy, G Wilkins, K Fung, W Boyko
Hypertension 1983
ALDOSTERONE IN SUSTAINED ESSENTIAL HYPERTENSION
ME Safar, AC SIMON, SA Dard, HR Parlier, NE Pauleau, ML Vincent, JE Sassard
Clinical Endocrinology 1982
INCREASED 18-HYDROXYCORTICOSTERONE RESPONSES TO FRUSEMIDE IN ESSENTIAL HYPERTENSION
PF Semple, PA Mason, R Fraser
Clinical Endocrinology 1980
Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity
WJ Lawton, AE Fitz
Hypertension 1980
Genetic aspects of plasma aldosterone binding globulins in families of patients with essential hypertension, including isolation of novel thermostable homologues from plasma and urine
W Nowaczynski, P Landais, T Murakami, M Nowaczynski, D Mavoungou, B Vitullo
Journal of Steroid Biochemistry 1979
Hormonal Steroids
W Nowaczynski, P Landais, T Murakami, M Nowaczynski, D Mavoungou, B Vitullo
Hormonal Steroids 1979
Role of the adrenal cortex and sodium in the pathogenesis of human hypertension
J Genest, W Nowaczynski, R Boucher, O Kuchel
Canadian Medical Association journal 1978
Effects of acth and posture on aldosterone metabolism in essential hypertension
W Nowaczynski, GP Guthrie, FH Messerli, J Genest, O Kuchel, M Honda, J Grose
Journal of Steroid Biochemistry 1977
The measurement of urinary tetrahydroaldosterone by radioimmunoassay
JH Pratt, MM Holbrook, SL Dale, JC Melby
Journal of Steroid Biochemistry 1977
Effects of angiotensin II on steroid metabolism and hepatic blood flow in man
FH Messerli, W Nowaczynski, M Honda, J Genest, R Boucher, O Kuchel, JM Rojo-Ortega
Circulation research 1977
Proceedings of the Fourth International Congress on Hormonal Steroids
RK Kalkhoff
Proceedings of the Fourth International Congress on Hormonal Steroids 1976
Proceedings of the 1975 Laurentian Hormone Conference
J Genest, W Nowaczynski, O Kuchel, R Boucher, J Rojo-Ortega, G Constantopoulos, D Ganten, F Messerli
Proceedings of the 1975 Laurentian Hormone Conference 1976
Plasma deoxycorticosterone and aldosterone in essential hypertension
M Honda, W Nowaczynski, FH Messerli, O Kuchel, J Genest
Journal of Steroid Biochemistry 1976
Enhanced aldosterone response to angiotensin II in human hypertension
ES Kisch, RG Dluhy, GH Williams
Circulation research 1976
Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity
FH Messerli, O Kuchel, W Nowaczynski, K Seth, M Honda, S Kubo, R Boucher, G Tolis, J Genest
Circulation 1976
Aldosterone and renin in essential hypertension
J Genest, W Nowaczynski, R Boucher, O Kuchel, JM Rojo-Ortega
Canadian Medical Association journal 1975
Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects
J Genest, R Boucher, O Kuchel, JM Rojo-Ortega, W Nowaczynski
Transactions of the American Clinical and Climatological Association 1975
Mineralocorticoid activity in patients in the early benign phase of essential hypertension
J Genest, W Nowaczynski, O Kuchel, F Messerli, R Boucher, M Rojo-Ortega
Journal of Steroid Biochemistry 1975
Decreased excretion of ring-A reduced steroid metabolites by hypertensive females
AC Dey, IR Senciall
Biochemical Medicine 1975
Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension
W Nowaczynski, O Küchel, J Genest, FH Messerli, M Honda, G Tolis, K Seth, R Parvin-Pande, S Kubo, J Grose, F Ledoux, M Lebel
Journal of Steroid Biochemistry 1975
Splanchnic blood flow in essential hypertension and in hypertensive patients with renal artery stenosis
FH Messerli, J Genest, W Nowaczynski, O Kuchel, M Honda, Y Latour, G Dumont
Circulation 1975
Perspectives on the renin-angiotensin-aldosterone system in hypertension
AH Vagnucci, AP Shapiro
Metabolism 1974
Radioimmuoassay for aldosterone and normal values under various physiological conditions
W Nowaczynski, C Sasaki, J Genest
Journal of Steroid Biochemistry 1974
Urinary Kallikrein Excretion in Hypertensive Man: Relationships to Sodium intake and Sodium-Retaining Steroids
HS Margolius, DA Horwitz, JJ Pisano, HR Keiser
Circulation research 1974
Angiotensin
IH Page, FM Bumpus
1974
Plasma aldosterone-renin interrelationships in various forms of essential hypertension
FR Bühler, JH Laragh, JE Sealey, HR Brunner
The American Journal of Cardiology 1973
New evidences of disturbances of mineralocorticoid activity in benign, uncomplicated essential hypertension
J Genest, WJ Nowaczynski, O Küchel, C Sasaki
Transactions of the American Clinical and Climatological Association 1972
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease
JH Laragh, L Baer, HR Brunner, FR Buhler, JE Vaughan
The American Journal of Medicine 1972

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts